Advanced Registry Search Results

Search Criteria
  1. Lobbyist name (consultant or in-house lobbyist): PERRY, GRANT OR;
  2. Senior Officer name: PERRY, GRANT
Start over
Modify criteria
Refine By
Document Type Registrations Status Activity Type Subject Matter of the Lobbying Activity Ministries/Provincial Entities

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Advanced Registry Search Results

Results: 1-11 of 11
  1. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: David Pidduck
    Registration: 14 of 17 (2019-08-13 to 2020-02-13)
    Posted: 2019-08-13
    Subject matter details: 2
    Lobbying target types: 1
    Government funding: No
    Employees who lobby: 3
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  2. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: David Pidduck
    Registration: 13 of 17 (2019-02-12 to 2019-08-12)
    Posted: 2019-02-12
    Subject matter details: 1
    Lobbying target types: 1
    Government funding: No
    Employees who lobby: 3
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  3. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: David Pidduck
    Registration: 12 of 17 (2018-07-16 to 2019-01-16)
    Posted: 2018-07-16
    Subject matter details: 1
    Lobbying target types: 1
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  4. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: David Pidduck
    Registration: 11 of 17 (2018-01-08 to 2018-07-08)
    Posted: 2018-01-08
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  5. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: David Pidduck
    Registration: 10 of 17 (2017-06-27 to 2017-12-27)
    Posted: 2017-06-27
    Subject matter details: 1
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  6. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Craig Landau
    Registration: 9 of 17 (2016-12-22 to 2017-06-20)
    Posted: 2016-12-22
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  7. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 8 of 17 (2016-03-29 to 2016-09-25)
    Posted: 2016-04-04
    Subject matter details: 1
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  8. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 7 of 17 (2015-09-29 to 2016-03-27)
    Posted: 2015-09-29
    Subject matter details: 1
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  9. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 5 of 17 (2014-10-01 to 2015-03-30)
    Posted: 2014-10-07
    Subject matter details: 1
    Lobbying target types: 1
    Government funding: No
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  10. GlaxoSmithKline Inc.
    Activity type: Organization
    Senior Officer: John Kelly
    Registration: 2 of 35 (2013-01-31 to 2013-08-29)
    Posted: 2013-03-01
    Subject matter details: 7
    Lobbying target types: 4
    Government funding: No
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  11. GlaxoSmithKline Inc.
    Activity type: Organization
    Senior Officer: John Kelly
    Registration: 1 of 35 (2010-05-19 to 2010-12-22)
    Posted: 2011-01-27
    Subject matter details: 5
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
Date Modified: